Researcher
Piet STINISSEN
- Keywords:Biomedical sciences (incl. biochemistry)
- Disciplines:Autoimmunity, Inflammation, Genetics, Neurological and neuromuscular diseases
Affiliations
- Limburg Clinical Research Center (Research Center)
Responsible
From1 Sep 2022 → Today - Immunology & Infection (Department)
Member
From1 Jan 2020 → Today - Immunology & Infection (Research group)
Member
From1 Jan 2020 → Today - Limburg Clinical Research Center (Research Center)
Member
From1 Jan 2020 → Today - Limburg Clinical Research Center (Research Center)
Responsible
From1 Jan 2020 → Today - Biomedical Research Institute (Research institute)
Member
From1 Oct 2005 → Today - Faculty of Medicine and Life Sciences (Faculty)
Member
From1 Jan 1999 → Today - Biomedical Research Institute (Research institute)
Responsible
From1 Oct 2005 → 10 Nov 2009 - Physiology - Biochemistry - Immunology (Department)
Member
From1 Oct 2003 → 31 Dec 2019 - Medical Basic Sciences (Division)
Member
From1 Jan 1999 → 30 Sep 2009 - Immunology - Biochemistry (Research group)
Member
From1 Jan 1992 → 31 Dec 2019 - Immunology - Biochemistry (Research group)
Responsible
From1 Jan 1992 → 31 Dec 2019
Projects
1 - 10 of 62
- IOF mandate Limburg Clinical Research Center (LCRC) 2024-2028From1 Jan 2024 → TodayFunding: IOF - mandates
- Structural funding of the LCRC centerFrom1 Jan 2024 → TodayFunding: BOF - research organisations
- Return to work through primary care: The development of a toolkit for general practitionersFrom1 Jan 2024 → TodayFunding: Department of Economy, Science and Innovation
- Donation agreement between Hasselt University, Mylan EPD BV and Noorderhart vzw regarding UMSC.From20 Dec 2022 → 20 Apr 2023Funding: Nonprofit institution or equivalents
- Integrated approach through first-line zones for reintegration into the labor market among the long-term sickFrom19 Dec 2022 → 18 Dec 2023Funding: Department of Economy, Science and Innovation
- Translational MS research UMSC.From29 Sep 2022 → 31 Dec 2022Funding: Industrial enterprises
- Unravelling the mechanism of single time vaccination strategy (SinTimVaS)From21 Feb 2022 → 31 Dec 2022Funding: BOF - projects
- NEURONET - Phase IIIFrom1 Feb 2022 → TodayFunding: BOF - Methusalem
- Deep immune-phenotyping of multiple sclerosis patients using advanced spectral flow cytometryFrom1 Jan 2022 → 31 Dec 2023Funding: Foundations, funds and other with scientific goal
- DigiPath: The introduction of digital pathology in LimburgFrom16 Dec 2021 → TodayFunding: Provinces, Own budget, for example: patrimony, inscription fees, gifts
Publications
141 - 150 of 158
- New Concepts on the Pathogenesis of Autoimmune Diseases: A Role for Immune Homeostasis, Immunoregulation, and Immunosenescence(2008)
Authors: Marielle THEWISSEN, Piet STINISSEN
Pages: 363 - 376 - Leukemia inhibitory factor modulates production of inflammatory mediators and myelin phagocytosis by macrophages(2008)
Authors: Jerome HENDRIKS, Leen SLAETS, Sofie CARMANS, Helga de Vries, Christine Dijkstra, Piet STINISSEN, Niels HELLINGS
Pages: 52 - 57 - T Cell Vaccination with CNS-derived CD4+ T-cells in Multiple Sclerosis: Rationale and immunological responses(2008)
Authors: Niels HELLINGS, Piet STINISSEN
Pages: 59 - 74 - Activation of myelin reactive T cells in multiple sclerosis: A possible role for T cell degeneracy?(2008)
Authors: Piet STINISSEN, Niels HELLINGS
Pages: 1190 - 1193 - Autoantibody profiling in multiple sclerosis: characterization of novel antigenic candidates(2008)
Authors: Veerle SOMERS, Cindy GOVARTS, Raymond Hupperts, Robert Medaer, Piet STINISSEN
Pages: S288 - S288 - Neuroprotective and immunomodulatory effects of leukemia inhibitory factor during neuroinflammatory responses in multiple sclerosis(2008)
Authors: Helena Slaets, Jerome HENDRIKS, Piet STINISSEN, Niels HELLINGS
Pages: S229 - S230 - Molecular evidence of glycine receptors on macrophages: A possible relationship with multiple sclerosis(2008)
Authors: Sofie CARMANS, Jerome HENDRIKS, Jean-Michel RIGO, Piet STINISSEN, Niels HELLINGS
Pages: 174 - 174 - Natural naive CD4(+)CD25(+)CD127(low) regulatory T cell (Treg) development and function are disturbed in multiple sclerosis patients: Recovery of memory treg homeostasis during disease progression(2008)
Authors: Koen VENKEN, Niels HELLINGS, Tom BROEKMANS, Karen HENSEN, Jean-Luc RUMMENS, Piet STINISSEN
Pages: 6411 - 6420 - Leukemia inhibitory factor is immunomodulatory(2008)
Authors: Jerome HENDRIKS, Leen SLAETS, Sofie CARMANS, E. de Vries, C. Dijkstra, Piet STINISSEN, Niels HELLINGS
Pages: 163 - 163 - Natural naive regulatory T cell development and function are disturbed in multiple sclerosis patients(2008)
Authors: Koen VENKEN, Niels HELLINGS, Karen HENSEN, Jean-Luc RUMMENS, Piet STINISSEN
Pages: S135 - S135
Patents
1 - 9 of 9
- Biomarkers for rheumatoid arthritis (Inventor)
- MEANS AND METHODS FOR THE DETERMINATION OF THE JOINT DESTRUCTION PROGRESSION RATE IN RHEUMATOID ARTHRITIS PATIENTS (Inventor)
- BIOMARKERS FOR MULTIPLE SCLEROSIS (Inventor)
- CITRULLINATION SPECIFIC PHAGE DISPLAY (Inventor)
- METABOLIC MARKERS FOR DIAGNOSING OF CANCER (Inventor)
- Biomarkers for rheumatoid arthritis (Inventor)
- CITRULLINATION SPECIFIC PHAGE DISPLAY (Inventor)
- Biomarkers for rheumatoid arthritis (Inventor)
- BIOMARKERS FOR RHEUMATOID ARTHRITIS (Inventor)